abor induction is common in modern obstetrics, with attention rightly directed toward the development of effective cervical ripening and induction techniques. Prostaglandin gel, intracervical mechanical devices, oral mifepristone, vaginal misoprostol, and extraamniotic saline infusions are some of the agents investigated in recent years. [1] [2] [3] [4] [5] [6] The safety and efficacy of single-agent therapy with prostaglandin E z (PGEz) gel for preinduction ripening of the cervix has been well documented. [4] [5] [6] [7] [8] [9] PGE z stimulates a change in the molecular structure of the cervix and can also cause uterine contractions. 9 There has been no documented increased risk of intrauterine infection with the use of this agent either intracervically or intravaginally. Hygroscopic cervical dilators have also been investigated as a single-agent method of preinduction cervical ripening.
6,1-These dilators absorb moisture through hygroscopic action, drawing fluid from the cervical stroma, resulting in softening of the tissue. As the dilators absorb fluid, axial expansion causes mechanical dilation of the cervix, as well as local production of endogenous prostaglandin that may contribute to their mechanism of action. -1 Findings on whether mechanical dilators promote an increase in intrauterine infection have not been consistent. 6,-1z In an attempt to shorten the time from indue- 
CONCLUSION
Combining hygroscopic cervical dilators with prostaglandin gel leads to more effective cervical ripening and a potentially more rapid induction to delivery interval than administering prostaglandin alone. Unfortunately, these benefits are outweighed by a significant and prohibitively high rate of intrauterine infection. While awaiting a larger, more comprehensive evaluation of these methods, the clinician faces the dilemma of whether achieving a more rapid delivery is worth the risk of the maternal infectious morbidity noted in our prospective trial.
